Nucleic acid polyhedra from self-assembled vertex-containing fixed-angle nucleic acid structures
US-2017015698-A1 · Jan 19, 2017 · US
US9796749B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9796749-B2 |
| Application number | US-201214237001-A |
| Country | US |
| Kind code | B2 |
| Filing date | Aug 2, 2012 |
| Priority date | Aug 5, 2011 |
| Publication date | Oct 24, 2017 |
| Grant date | Oct 24, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The invention provides nucleic acid structures of controlled size and shape, comprised of a plurality of oligonucleotides, and methods for their synthesis. The structures are formed, at least in part, by the self-assembly of single stranded oligonucleotides. The location of each oligonucleotide in the resultant structure is known. Accordingly, the structures may be modified with specificity.
Opening claim text (preview).
What is claimed is: 1. A nucleic acid structure comprising a plurality of oligonucleotides, wherein at least one oligonucleotide of the plurality comprises at least four domains, wherein each of the four domains is annealed to a complementary domain of another oligonucleotide of the plurality to form at least two parallel double helices within the nucleic acid structure, wherein oligonucleotides having single-stranded poly(T), poly(A) or poly(C) domains that each have a length of 4-22 nucleotides are present at borders around the nucleic acid structure. 2. The nucleic acid structure of claim 1 , wherein at least one double helix within the nucleic acid structure comprises 2 or more unique domains. 3. The nucleic acid structure of claim 1 , wherein at least 50% of the double helices within the nucleic acid structure comprise one or more unique domains. 4. The nucleic acid structure of claim 1 , wherein the nucleic acid structure comprises at least 5, at least 10, or at least 20 parallel double helices. 5. The nucleic acid structure of claim 1 , wherein a first subset of oligonucleotides of the plurality comprises 2 domains and a second subset of oligonucleotides of the plurality comprises 4 domains. 6. The nucleic acid structure of claim 1 , wherein the oligonucleotides are 21-104 nucleotides in length. 7. The nucleic acid structure of claim 1 , wherein the oligonucleotides are DNA oligonucleotides. 8. The nucleic acid structure of claim 1 , wherein the oligonucleotides are L-DNA oligonucleotides. 9. The nucleic acid structure of claim 1 , wherein at least one of the double helices within the nucleic acid structure is unique. 10. The nucleic acid structure of claim 9 , wherein the nucleic acid structure comprises 2 or more unique double helices. 11. The nucleic acid structure of claim 9 , wherein at least 50% of the double helices are unique. 12. The nucleic acid structure of claim 9 , wherein at least 50% of the double helices comprise one or more unique domains. 13. The nucleic acid structure of claim 9 , wherein the nucleic acid structure comprises at least 5, at least 10, or at least 20 parallel double helices. 14. The nucleic acid structure of claim 9 , wherein a first subset of oligonucleotides of the plurality comprises 2 domains and a second subset of oligonucleotides of the plurality comprises 4 domains. 15. The nucleic acid structure of claim 1 , wherein at least one oligonucleotide in the nucleic acid structure is unique. 16. A composition comprising a plurality of nucleic acid structures of claim 1 , wherein at least 50% of the nucleic acid structures of the plurality are identical. 17. A composite nucleic acid structure comprising at least two nucleic acid structures of claim 1 , conjugated to each other through a spacer-linker. 18. The nucleic acid structure of claim 1 , wherein the nucleic acid structure has an internal void pattern. 19. The nucleic acid structure of claim 1 , wherein the nucleic acid structure further comprises oligonucleotides having a handle domain. 20. The nucleic acid structure of claim 19 , wherein the oligonucleotides having a handle domain are present at borders of the nucleic acid structure. 21. The nucleic acid structure of claim 19 , wherein the handle domain is bound to an oligonucleotide conjugated to a moiety of interest. 22. The nucleic acid structure of claim 1 , wherein the single-stranded poly(T), poly(A) or poly(C) domains have a length of 10 nucleotides. 23. The nucleic acid structure of claim 1 , wherein the single-stranded poly(T), poly(A) or poly(C) domains have a length of 11 nucleotides.
incorporating a spacer/coupling moiety · CPC title
incorporating target specific and non-target specific sites · CPC title
Nanotubes or nanorods · CPC title
being a biochannel or pore · CPC title
incorporating bases where the precise position of the bases in the nucleic acid string is important · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.